STARGARDT

Clinical trials for STARGARDT explained in plain language.

Never miss a new study

Get alerted when new STARGARDT trials appear

Sign up with your email to follow new studies for STARGARDT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

First-in-Human gene therapy trial aims to halt inherited blindness

Disease control Not yet recruiting

This is a very early, first-in-human study to check if a new gene therapy drug called ZVS106e is safe for people with Stargardt disease, a genetic condition that causes vision loss. It will involve 9 participants who have a specific genetic mutation. Doctors will inject the drug …

Matched conditions: STARGARDT

Phase: EARLY_PHASE1 • Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

STARGARDT

Get alerted when new STARGARDT trials appear

First-in-Human gene therapy trial aims to halt inherited blindness